GENE ONLINE|News &
Opinion
Blog

Gene Editing
Special Prime Editing
New Age Gene Editors Take Us Closer to CRISPR-Based Gene Therapy
2021-10-28
Licensing CRISPR
Vertex Signs $700 Million worth CRISPR Pact with Jennifer Doudna Co-founded Gene Editing Firm
2021-10-26
MD Anderson to Develop Microbiome Cancer Therapeutics with CRISPR Gene-Editing
2021-09-14
Special Gene Editing
Researchers Engineer “Mini” CRISPR-Cas System That Could Act as ‘Swiss Army Knife’ for Mammalian Genome Editing
2021-09-07
RNA Editing
New Era in Precision Medicine? Introduction & Overview of RNA Editing
2021-08-23
Innovation Gene Therapy
Scientists Develop Drug Inducible Switch to Regulate Gene Therapy
2021-08-18
CRISPR
Germline Editing in Marsupials Marks Another Milestone for CRISPR
2021-08-01
Asia-Pacific Precision Medicine
The Future of Precision Medicine: From Gene Therapy to Data Sharing Boom – Excerpts from the US-Taiwan Precision Medicine Forum
2021-07-21Partner
Technology CRISPR
Primed to Surpass CRISPR: Prime Medicine Emerges Out of Stealth with $315 Million in Funding
2021-07-15
Trials & Approvals Gene Editing
A New Era Begins! Intellia Reports First Clinical Proof for Direct CRISPR Genome Editing in Humans
2021-06-27
Technology CRISPR
New Technique Could Challenge CRISPR by Editing Millions of DNA Sites Simultaneously
2021-05-20
Technology CRISPR
The Game Changer: New CRISPR Tool Can Turn On/Off Genes
2021-05-03
Technology CRISPR
CRISPR Gene Editing Could Lead to Possible Detrimental Chromosomal Rearrangement
2021-04-25
Technology CRISPR
Vertex to Reap Majority Profits from Gene Editing Deal with CRISPR Therapeutics
2021-04-21
Deals CRISPR
Inscripta Raises New Capital, Hits a Sales Milestone the Same Day
2021-04-07
1 2 3 4 … 6
LATEST
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top